Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.45 USD
−6.04 M USD
0.00 USD
1.33 M
About Synaptogenix, Inc.
Sector
CEO
Alan J. Tuchman
Headquarters
New York
Website
Founded
2012
FIGI
BBG00YG4Q0S0
Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company was founded on October 31, 2012 and is headquartered in New York, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SNPX is 3.07 USD — it has increased by 19.69% in the past 24 hours. Watch Synaptogenix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Synaptogenix, Inc. stocks are traded under the ticker SNPX.
SNPX stock has risen by 11.24% compared to the previous week, the month change is a 22.31% rise, over the last year Synaptogenix, Inc. has showed a −54.52% decrease.
SNPX reached its all-time high on Oct 13, 2021 with the price of 362.50 USD, and its all-time low was 2.32 USD and was reached on Nov 15, 2024. View more price dynamics on SNPX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SNPX stock is 21.27% volatile and has beta coefficient of 1.17. Track Synaptogenix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Synaptogenix, Inc. there?
Today Synaptogenix, Inc. has the market capitalization of 3.48 M, it has decreased by −8.76% over the last week.
Yes, you can track Synaptogenix, Inc. financials in yearly and quarterly reports right on TradingView.
Synaptogenix, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
SNPX net income for the last quarter is −5.74 M USD, while the quarter before that showed −1.27 M USD of net income which accounts for −350.95% change. Track more Synaptogenix, Inc. financial stats to get the full picture.
No, SNPX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 21, 2024, the company has 8.00 employees. See our rating of the largest employees — is Synaptogenix, Inc. on this list?
Like other stocks, SNPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Synaptogenix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Synaptogenix, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Synaptogenix, Inc. stock shows the sell signal. See more of Synaptogenix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.